VKTX vs. SCHD

Last updated Aug 1, 2026

VKTX (Viking Therapeutics, Inc.) is a stock, while SCHD (Schwab U.S. Dividend Equity ETF) is Dividend fund tracking the Dow Jones U.S. Dividend 100 Index. Over the past 10 years, VKTX returned 36.63%/yr vs 12.76%/yr for SCHD. Their 0.21 correlation means their historical movements had little consistent relationship.

Performance

VKTX vs. SCHD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Viking Therapeutics, Inc. (VKTX) and Schwab U.S. Dividend Equity ETF (SCHD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VKTX achieves a -9.78% return, which is significantly lower than SCHD's 24.03% return. Over the past 10 years, VKTX has outperformed SCHD with an annualized return of 36.63%, while SCHD has yielded a comparatively lower 12.76% annualized return.

VKTX

• 1D: -4.14%
• 1M: -15.22%
• 6M: 9.30%
• YTD: -9.78%
• 1Y: -2.88%
• 3Y*: 30.87%
• 5Y*: 38.85%
• 10Y*: 36.63%
• ALL TIME*: 12.42%

SCHD

• 1D: 0.18%
• 1M: 3.33%
• 6M: 14.09%
• YTD: 24.03%
• 1Y: 31.54%
• 3Y*: 14.19%
• 5Y*: 9.54%
• 10Y*: 12.76%
• ALL TIME*: 13.39%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
SCHD Schwab U.S. Dividend Equity ETF	$786.88M	$715.86M	$685.58M
VKTX Viking Therapeutics, Inc.	$78.34M	$82.45M	$79.18M

VKTX vs. SCHD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VKTX Viking Therapeutics, Inc.	-9.78%	-12.57%	116.23%	97.98%	104.35%	-18.29%	-29.80%	4.84%	88.42%	241.18%
SCHD Schwab U.S. Dividend Equity ETF	24.03%	4.34%	11.66%	4.54%	-3.26%	29.87%	15.03%	27.29%	-5.56%	20.85%

Correlation

The correlation between VKTX and SCHD is 0.12, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.12
Correlation (3Y) Balances recent behavior with more history.	0.23
Correlation (5Y) Shows whether the relationship held over a longer period.	0.23
Correlation (10Y) Provides a long-term view across more market conditions.	0.24
Correlation (All Time) Calculated using the full available price history since Apr 29, 2015	0.21

The correlation between VKTX and SCHD shifts across timeframes, from 0.12 (1 year) to 0.24 (10 years), reflecting how their relationship changes across market environments.

Return for Risk

VKTX vs. SCHD — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

VKTX

VKTX Risk / Return Rank: 45
VKTX Sharpe Ratio Rank: 43
VKTX Sortino Ratio Rank: 47
VKTX Omega Ratio Rank: 49
VKTX Calmar Ratio Rank: 42
VKTX Martin Ratio Rank: 42

SCHD

SCHD Risk / Return Rank: 95
SCHD Sharpe Ratio Rank: 96
SCHD Sortino Ratio Rank: 96
SCHD Omega Ratio Rank: 94
SCHD Calmar Ratio Rank: 96
SCHD Martin Ratio Rank: 93

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

VKTX vs. SCHD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Viking Therapeutics, Inc. (VKTX) and Schwab U.S. Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VKTX	SCHD	Difference
Sharpe ratio: Return per unit of total volatility	-0.03	2.81	-2.85
Sortino ratio: Return per unit of downside risk	0.50	4.37	-3.87
Omega ratio: Gain probability vs. loss probability	1.08	1.51	-0.43
Calmar ratio: Return relative to maximum drawdown	-0.06	6.74	-6.79
Martin ratio: Return relative to average drawdown	-0.11	17.01	-17.12

VKTX vs. SCHD - Sharpe Ratio Comparison

The current VKTX Sharpe Ratio is -0.03, which is lower than the SCHD Sharpe Ratio of 2.81. The chart below compares the historical Sharpe Ratios of VKTX and SCHD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

VKTX vs. SCHD - Drawdown Comparison

The maximum VKTX drawdown since its inception was -90.41%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for VKTX and SCHD.

Drawdown Indicators

	VKTX	SCHD	Difference
Max Drawdown Largest peak-to-trough decline	-90.41%	-33.37%	-57.04%
Max Drawdown (1Y) Largest decline over 1 year	-45.14%	-4.61%	-40.53%
Max Drawdown (3Y) Largest decline over 3 years	-78.86%	-16.13%	-62.73%
Max Drawdown (5Y) Largest decline over 5 years	-78.86%	-16.85%	-62.01%
Max Drawdown (10Y) Largest decline over 10 years	-89.26%	-33.37%	-55.89%
Current Drawdown Current decline from peak	-66.41%	-1.24%	-65.17%
Average Drawdown Average peak-to-trough decline	-60.03%	-3.30%	-56.73%
Ulcer Index Depth and duration of drawdowns from previous peaks	23.55%	1.82%	+21.73%

Volatility

VKTX vs. SCHD - Volatility Comparison

Viking Therapeutics, Inc. (VKTX) has a higher volatility of 16.06% compared to Schwab U.S. Dividend Equity ETF (SCHD) at 4.11%. This indicates that VKTX's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VKTX	SCHD	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.06%	4.11%	+11.95%
Volatility (6M) Calculated over the trailing 6-month period	41.26%	8.11%	+33.15%
Volatility (1Y) Calculated over the trailing 1-year period	74.46%	11.13%	+63.33%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	101.84%	14.39%	+87.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	97.12%	16.72%	+80.40%

Dividends

VKTX vs. SCHD - Dividend Comparison

VKTX has not paid dividends to shareholders, while SCHD's dividend yield for the trailing twelve months is around 3.13%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SCHD Schwab U.S. Dividend Equity ETF	3.13%	3.82%	3.64%	3.49%	3.39%	2.78%	3.16%	2.98%	3.06%	2.63%	2.89%	2.97%
VKTX Viking Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both VKTX and SCHD in my portfolio?

VKTX and SCHD have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VKTX or SCHD?

VKTX has higher volatility (16.06%) compared to SCHD (4.11%). In terms of maximum drawdown, VKTX dropped -90.41% vs SCHD's -33.37%.

Which has better risk-adjusted returns?

SCHD currently has the higher Sharpe Ratio (2.81 vs -0.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.